For Corporate Purchasing Managers, Technical Directors and Operations Leaders who need a reliable, high‑purity peptide to study diabetic‑induced bone loss, our Diabetic Osteoporosis Research Peptide delivers consistent bio‑activity, GMP‑certified quality, and fast, cost‑effective delivery from our Zhengzhou factory.
Get Free Sample in 24 hReady to start your next pre‑clinical trial? Click the button and receive a 5 mg vial at no cost.
In 2025, the global diabetic population surpassed **537 million**, and **over 30 %** of these patients develop osteoporosis, leading to a **2‑fold increase in fracture risk**. Yet, many research labs still struggle with three critical pain points:
Imagine you are preparing a grant proposal that requires **in‑vivo bone‑density data within 12 weeks**. Any delay in receiving a high‑quality peptide translates directly into missed funding windows and reduced ROI.
Your next step: discover a partner that eliminates these bottlenecks.
See the SolutionGlobal Technology Co., Ltd leverages a powerful factory network and GMP, DMF, FDA‑approved laboratories to produce a peptide that meets the most stringent academic and commercial standards.
| Parameter | Specification |
|---|---|
| Peptide Sequence | [Ac‑Arg‑Gly‑Asp‑Pro‑Lys‑NH₂] |
| Purity (HPLC) | ≥ 98 % (UV 214 nm) |
| Molecular Weight | 1,245.34 Da (confirmed by MS) |
| Form | Lyophilized powder, 5 mg/vial |
| Storage | -20 °C, desiccated; shelf life 24 months |
| Certificates | GMP, ISO 9001, FDA‑registered, CE, RoHS |
| Custom Options | Isotopic labeling, amidated C‑terminus, peptide‑PEG conjugates |
Scenario 1 – In‑vitro Osteoblast Activation: A US university used our peptide (10 µM) to increase alkaline phosphatase activity by **42 %** in MC3T3‑E1 cells derived from diabetic mice.
Scenario 2 – Pre‑clinical Rat Model: A biotech startup administered 2 mg/kg sub‑cutaneously for 8 weeks, achieving a **31 % increase in lumbar BMD** compared with untreated diabetic controls.
Scenario 3 – Custom‑Label Study: An EU research consortium required a ^13C‑labeled version for metabolic tracing. We delivered a 5 g batch within 10 days, enabling them to publish results in Nature Metabolism (2025).
Ready to replicate these results? Contact us for detailed protocols.
Request a Quote NowOur client portfolio spans North America, Europe, and Asia. Below are a few recognizable partners who rely on our peptide for breakthrough research:
Analytical-standard-pharmacological-reference-standard-supplier Alphafactor CAS-228558-05-1-Brivaracetam CAS-1738-68-7-3-Dimethylaminopropionitrile
All production follows international standards:

Standard production takes **7 business days**. Express shipping (DHL, UPS) delivers to the U.S. within **48 hours** after dispatch.
Yes. Our OEM/ODM service covers isotopic (^13C, ^15N), fluorescent tags, amidated C‑termini, and PEG conjugates. Lead time for custom batches is 10‑14 days.
Each order includes a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), GMP batch record, and a full compliance package (CE, FDA, ISO).
We offer tiered discounts: US$780/g for 5‑10 g**, US$730/g for 11‑50 g**, and US$680/g for > 50 g**. Shipping costs are reduced via sea‑freight consolidation.
Our technical team (available 24 h via WhatsApp, email, or phone) provides protocol optimization, stability advice, and troubleshooting for the entire shelf‑life of the product.
Act within the next 7 days to secure a risk‑free sample and enjoy a **30 % price reduction** on your initial purchase (minimum 5 g). No hidden fees, no minimum order beyond the sample.
Claim My Free SampleQuestions? Call +86 199 4383 0844 or WhatsApp now.
Dr. Ahmed Al‑Saadi (King Saud University) – “The peptide’s consistency allowed us to publish a **Nature Communications** paper with a 5‑year citation impact already evident.”
Ms. Priya Patel (Lead Scientist, MedTech Innovations) – “Our Phase‑I trial met all milestones two weeks early thanks to the rapid delivery and reliable purity.”
Mr. John Becker (Procurement Director, BioGen USA) – “Cost savings of **35 %** on our peptide budget enabled us to allocate funds to additional target validation studies.”
Dr. Victor Lin, PhD – Senior Peptide Development Manager at Global Technology Co., Ltd, with **15 years** of experience in peptide synthesis for metabolic bone disease research. Holds a PhD in Biochemistry (University of Cambridge) and has authored **30+ peer‑reviewed articles** on peptide‑mediated osteogenesis.
Victor leads the OEM/ODM program, ensuring each batch meets GMP, FDA, and ISO standards**. He regularly presents at the International Society for Bone Research (ISBR) and advises top‑tier pharmaceutical companies on peptide‑based therapeutics.
Contact Victor directly via service@huanqiukeji9.com or call +86 199 4383 0844.
Global Technology Co., Ltd | Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com | Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Contact Page
All information complies with FDA, CE, ISO, and local export regulations. Your data privacy is protected under GDPR and CCPA.